Illumina Wins Favorable Ruling In Patent Suit

San Diego-based life sciences equipment maker Illumina said Thursday that it has received a favorable outcome in its patent litigation against Life Technologies. Illumina said that a judge in the U.S. District Court for the Southern District of California granted it summary judgement, saying that its sequencing systems do not infringe U.S. Patent Nos. 5,616,478; 5,958,698 and 6,001,568, which are owned by Life Technologies. Life Technologies sued Illumina over the patents in 2009. The ruling comes only days fater Illumina was ordered to pay $96M in another patent lawsuit involving Syntrix Biosystems. The life sciences and sequencing market seems to be a hotbed of patent lawsuits; Illumina is also engaged in another patent lawsuit fight with Complete Genomics, and also had sued Affymetrix in 2009.